Nymox launches AD7C Alzheimer's disease testing service; test kit in development.
This article was originally published in The Gray Sheet
Executive Summary
NYMOX BEGINS OFFERING AD7C ALZHEIMER'S TEST SERVICE through its clinical labs in Rockville, Maryland and Montreal, Canada. The test, which utilizes a recombinant version of neural thread protein to help physicians diagnose Alzheimer's Disease, is priced at $1,000, the company says.